{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:04:14Z","timestamp":1789718654332,"version":"4.0.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"vor","delay-in-days":154,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.prdoa.2024.100260","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T21:03:28Z","timestamp":1718226208000},"page":"100260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Botulinum toxin therapy in Parkinson disease-related lower limb dystonia. An 8\u00a0year retrospective review"],"prefix":"10.1016","volume":"11","author":[{"given":"Antonia","family":"Schonwald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Amodeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2297-9232","authenticated-orcid":false,"given":"Fabio","family":"Danisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.prdoa.2024.100260_b0005","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.parkreldis.2008.01.012","article-title":"The spectrum of disorders presenting as adult-onset focal lower extremity dystonia","volume":"14","author":"McKeon","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1","key":"10.1016\/j.prdoa.2024.100260_b0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.parkreldis.2005.07.004","article-title":"Adult-onset primary focal foot dystonia","volume":"12","author":"Singer","year":"2006","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.prdoa.2024.100260_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.05.001","article-title":"Dystonia and Parkinson's disease: What is the relationship?","volume":"132","author":"Shetty","year":"2019","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.prdoa.2024.100260_b0020","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/mds.23469","article-title":"The motor phenotype of Parkinson's disease in relation to age at onset","volume":"26","author":"Wickremaratchi","year":"2011","journal-title":"Movement Disord."},{"issue":"Suppl 7","key":"10.1016\/j.prdoa.2024.100260_b0025","first-page":"VII7 -13","article-title":"Dystonia in Parkinson's disease","volume":"253","author":"Tolosa","year":"2006","journal-title":"J. Neurol."},{"key":"10.1016\/j.prdoa.2024.100260_b0030","first-page":"361","article-title":"Treatment of dystonia in Parkinson's disease","volume":"91","author":"Tsui","year":"2003","journal-title":"Adv. Neurol."},{"issue":"3","key":"10.1016\/j.prdoa.2024.100260_b0035","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/brain\/121.3.451","article-title":"Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson\u2019s disease","volume":"121","author":"Krack","year":"1998","journal-title":"Brain: J. Neurol."},{"issue":"3","key":"10.1016\/j.prdoa.2024.100260_b0040","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/mds.870100317","article-title":"\u201cOff\u201d painful dystonia in Parkinson\u2019s disease treated with botulinum toxin","volume":"10","author":"Pacchetti","year":"1995","journal-title":"Movement Disord."},{"key":"10.1016\/j.prdoa.2024.100260_b0045","first-page":"1","article-title":"Effects of Onabotulinum Toxin A on Gait in Parkinson\u2019s Disease Patients with Foot Dystonia","author":"Huang","year":"2021","journal-title":"Canad. J. Neurol. Sci. \/ Journal Canadien Des Sciences Neurologiques."},{"key":"10.1016\/j.prdoa.2024.100260_b0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.parkreldis.2017.10.009","article-title":"Incobotulinum toxin A in Parkinson's disease with foot dystonia: A double blind randomized trial","volume":"46","author":"Rieu","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"issue":"2","key":"10.1016\/j.prdoa.2024.100260_b0055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3390\/toxins13020087","article-title":"Use of Botulinum Neurotoxin in Parkinson's Disease: A Critical Appraisal","volume":"13","author":"Jost","year":"2021","journal-title":"Toxins (Basel)"},{"issue":"6","key":"10.1016\/j.prdoa.2024.100260_b0060","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2340\/16501977-2094","article-title":"Botulinum toxin for foot dystonia in patients with Parkinson's disease having deep brain stimulation: a case series and a pilot study","volume":"48","author":"Gupta","year":"2016","journal-title":"J. Rehabil. Med."},{"key":"10.1016\/j.prdoa.2024.100260_b0065","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.toxicon.2017.08.018","article-title":"Botulinum toxin in parkinsonism: the when, how, and which for botulinum toxin injections","volume":"147","author":"Cardoso","year":"2018","journal-title":"Toxicon"},{"issue":"2","key":"10.1016\/j.prdoa.2024.100260_b0070","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3390\/toxins13020155","article-title":"The Central Effects of Botulinum Toxin in Dystonia and Spasticity","volume":"13","author":"Hok","year":"2021","journal-title":"Toxins (Basel)"},{"issue":"1","key":"10.1016\/j.prdoa.2024.100260_b0075","article-title":"Postural deformities in Parkinson\u2019s disease -Mutual relationships among neck flexion, fore-bent, knee-bent and lateral-bent angles and correlations with clinical predictors. Journal of Clinical","volume":"3","author":"Yoshii","year":"2016","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.prdoa.2024.100260_b0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jns.2005.07.012","article-title":"Lower limb post-immobilization dystonia in Parkinson\u2019s disease","volume":"239","author":"Singer","year":"2005","journal-title":"J. Neurol. Sci."},{"issue":"11","key":"10.1016\/j.prdoa.2024.100260_b0085","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1212\/01.WNL.0000163767.99354.C3","article-title":"A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia","volume":"64","author":"Benecke","year":"2005","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.prdoa.2024.100260_b0090","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00702-018-1897-x","article-title":"Comparing incobotulinumtoxinA (Xeomin\u00ae) and onabotulinumtoxinA (Botox\u00ae): identical potency labelling in the hemidiaphragm assay","volume":"125","author":"Dressler","year":"2018","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.prdoa.2024.100260_b0095","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/mds.26081","article-title":"Effect of neurostimulation on camptocormia in Parkinson's disease depends on symptom duration","volume":"30","author":"Schulz-Schaeffer","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.prdoa.2024.100260_b0100","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/mds.870030107","article-title":"Analysis of open-label trials in torsion dystonia using high dosages of anticholinergics and other drugs","volume":"3","author":"Greene","year":"1988","journal-title":"Mov. Disord."},{"key":"10.1016\/j.prdoa.2024.100260_b0105","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/mds.870070109","article-title":"Baclofen in the treatment of idiopathic dystonia in children","volume":"7","author":"Greene","year":"1992","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.prdoa.2024.100260_b0110","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1227\/NEU.0b013e318258e21b","article-title":"Shorter disease duration correlates with improved long-term deep brain stimulation outcomes in young-onset DYT1 dystonia","volume":"71","author":"Markun","year":"2012","journal-title":"Neurosurgery"},{"key":"#cr-split#-10.1016\/j.prdoa.2024.100260_b0115.1","doi-asserted-by":"crossref","unstructured":"A. Priori, A. Pesenti, A. Cappellari, G. Scarlato, S. Barbieri. Limb immobilization for the treatment of focal occupational dystonia. Neurology Aug 2001, 57","DOI":"10.1212\/WNL.57.3.405"},{"key":"#cr-split#-10.1016\/j.prdoa.2024.100260_b0115.2","unstructured":"(3) 405-409. [and PERSONAL COMMUNICATION, 2002]."},{"issue":"12","key":"10.1016\/j.prdoa.2024.100260_b0120","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/archneur.1991.00530240057020","article-title":"Clinical Correlates of Response to Botulinum Toxin Injections","volume":"48","author":"Jankovic","year":"1991","journal-title":"Arch. Neurol."}],"container-title":["Clinical Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590112524000318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590112524000318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T06:31:31Z","timestamp":1734589891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590112524000318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":25,"alternative-id":["S2590112524000318"],"URL":"https:\/\/doi.org\/10.1016\/j.prdoa.2024.100260","relation":{},"ISSN":["2590-1125"],"issn-type":[{"value":"2590-1125","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Botulinum toxin therapy in Parkinson disease-related lower limb dystonia. An 8\u00a0year retrospective review","name":"articletitle","label":"Article Title"},{"value":"Clinical Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prdoa.2024.100260","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100260"}}